| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/2009 | EP2046384A2 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 04/15/2009 | EP2046383A1 Cd20 binding molecules for the treatment of copd |
| 04/15/2009 | EP2046382A2 scFv ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS |
| 04/15/2009 | EP2046381A1 Cancerous disease modifying antibodies |
| 04/15/2009 | EP2046380A2 Human endogenous retrovirus polypeptide compositions and methods of use thereof |
| 04/15/2009 | EP2046379A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 04/15/2009 | EP2046378A2 Use of bacterial polysaccharides for biofilm inhibition |
| 04/15/2009 | EP2046377A1 Method of protecting against staphylococcal infection |
| 04/15/2009 | EP2046376A2 Vaccines and methods for controlling adiposity |
| 04/15/2009 | EP2046374A2 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 04/15/2009 | EP2046370A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 04/15/2009 | EP2046366A2 Method of treatment of age-related macular degeneration |
| 04/15/2009 | EP2046344A2 Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes |
| 04/15/2009 | EP2046331A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 04/15/2009 | EP1690549B1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 04/15/2009 | EP1562628B1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 04/15/2009 | EP1523503B1 Therapeutic antibodies with reduced side effects |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |
| 04/15/2009 | EP1385547B1 Antibody which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 04/15/2009 | EP1383796B1 Neurovirulent strain of the west nile virus and applications thereof |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | EP1079854B1 Compositions and methods of modulating an immune response to an antigen by administration of cytokine-coated cells |
| 04/15/2009 | CN101410528A Methods for modulating mannose content of recombinant proteins |
| 04/15/2009 | CN101410519A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/15/2009 | CN101410414A Synergistic compositions for treating HIV-1 |
| 04/15/2009 | CN101410413A Anti-EPHRINB2 antiboies and methods using same |
| 04/15/2009 | CN101410140A Engineered antibody-stress protein fusions |
| 04/15/2009 | CN101410138A New immunoglobulin concentrate useful as medicament for chikungunya virus |
| 04/15/2009 | CN101410137A Anti-IGF-1R human monoclonal antibody formulation |
| 04/15/2009 | CN101410136A Concentrate of immunoglobulins and F(ab)'2 and/or Fab fragments specific of an arbovirus as medicine |
| 04/15/2009 | CN101410135A Immunogenic composition |
| 04/15/2009 | CN101410134A Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 04/15/2009 | CN101410133A dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 04/15/2009 | CN101410132A GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 04/15/2009 | CN101407782A Oral DNA vaccine for promoting growth of animal by non-antibiotics resistance gene screening, and preparation and use thereof |
| 04/15/2009 | CN101407781A Inhibin DNA vaccine capable of improving animal fertility, and preparation and use thereof |
| 04/15/2009 | CN101407546A Human anti-human tumor necrosis factor-alpha single chain antibody |
| 04/15/2009 | CN101407545A 131I labeled anti-tumor humanized monoclonal antibody 1E2 and use thereof |
| 04/15/2009 | CN101406702A Method for enhancing immunocompetence of nucleic acid vaccine using SOCS1 interfere technique |
| 04/15/2009 | CN101406701A Adjuvant capable of improving dendritic cell vaccine efficiency |
| 04/15/2009 | CN101406700A Mixed immunity antigen and use thereof in establishing monoclonal antibody hybridoma cell strain |
| 04/15/2009 | CN101406699A Method for preparing lyophilized hepatitis A attenuated live vaccine using cell factory |
| 04/15/2009 | CN101406698A Dog type II adenovirus live vector recombinant vaccine for displaying protective antigen of rabies virus |
| 04/15/2009 | CN101406697A Bacillus pyocyaneus vaccine and preparation method thereof |
| 04/15/2009 | CN101406696A Vaccine comprising a tick cement protein |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478028C Genetic engineering vaccine of enterohemorrhagic escherichia coli O157:H7 and the preparing method thereof |
| 04/15/2009 | CN100478027C Catheter composition and uses thereof for preparing medicine |
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517964 RS7 antibodies |
| 04/14/2009 | US7517963 Tumour necrosis factor binding ligands |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517961 Homogeneous preparations of IL-28 and IL-29 |
| 04/14/2009 | US7517955 Lactoferrin binding protein for use in diagnosis, treatment and prevention of streptococcal pathogen infection |
| 04/14/2009 | US7517952 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/14/2009 | US7517950 polypeptide that binds to major histocompatibility complex (MHC) proteins and induces cytotoxic t lymphocytes when bound to MHC antigens; anticancer vaccines |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517862 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517683 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 04/14/2009 | US7517670 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2009 | US7517666 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517654 polypeptides used as wound healing agents, tissue regeneration, inhibition of cancer metastesis mediated by extracellular matrix protein including laminin |
| 04/14/2009 | US7517533 Pseudomonas aeruginosa antigens |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | US7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 04/14/2009 | US7517529 Using gene-regulatory peptide |
| 04/14/2009 | US7517527 Immunotoxin with in vivo T cell suppressant activity and methods of use |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | US7517525 Methods of inhibiting amyloid toxicity |
| 04/14/2009 | US7517524 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | US7517520 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 04/14/2009 | US7517518 Using expression of tumor marker protein (CA 125) as indicator of bacterial infection |
| 04/14/2009 | CA2318576C Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2225852C Anti-fas ligand antibody and assay method using the anti-fas ligand antibody |
| 04/14/2009 | CA2208237C Nuclear protein serine/threonine kinases |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/09/2009 | WO2009046451A1 Recombinant bacterium capable of eliciting a protective immune response against c. perfringens |
| 04/09/2009 | WO2009046449A1 Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
| 04/09/2009 | WO2009046407A2 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/09/2009 | WO2009046405A2 Antibodies to htra1 and methods of using the same |
| 04/09/2009 | WO2009046168A1 Antibody therapy for use in the digestive tract |
| 04/09/2009 | WO2009046147A1 Imageable rodent model of asthma |
| 04/09/2009 | WO2009046123A2 Nlrr-1 antagonists and uses thereof |
| 04/09/2009 | WO2009046015A2 Combination therapies for treating type 1 diabetes |
| 04/09/2009 | WO2009045957A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | WO2009045575A2 Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins |
| 04/09/2009 | WO2009045504A1 Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways |
| 04/09/2009 | WO2009045464A1 Methods of treating neurological autoimmune disorders with cyclophosphamide |
| 04/09/2009 | WO2009045308A2 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 04/09/2009 | WO2009045179A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 04/09/2009 | WO2009044774A1 Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient |
| 04/09/2009 | WO2009044555A1 Preparation and method of administering vaccine and iontophoresis device using the preparation |